Coronary sinus reducer not beneficial in patients with ANOCA
In patients with refractory angina and coronary microvascular dysfunction but no obstructed coronary arteries, a coronary sinus reducer did not improve coronary microvascular function, symptoms and quality of life, researchers reported.
The single-center investigator-initiated REMEDY-PILOT trial, presented at TCT 2026, compared the performance of a coronary sinus reducer (Shockwave Reducer, Shockwave Medical) with a sham procedure at improving endocardial myocardial perfusion reserve, symptoms and quality of life.
“In patients undergoing investigation for angina with nonobstructed coronary